The epigenetic modifiers 5-aza-2'-deoxycytidine
and trichostatin A influence adipocyte differentiation in human mesenchymal stem
cells

The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells

Epigenetic mechanisms such as DNA methylation and histone modification are important in stem cell differentiation. Methylation is principally associated with transcriptional repression, and histone acetylation is correlated with an active chromatin state. We determined the effects of these epigeneti...

Full description

Bibliographic Details
Main Authors:	Zych, J., Stimamiglio, M.A., Senegaglia, A.C., Brofman, P.R.S., Dallagiovanna, B., Goldenberg, S., Correa, A.
Format:	Online
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854397/

Similar Items

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
by: Meng, F, et al.
Published: (2013)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
by: Chen, X, et al.
Published: (2013)

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
by: Momparler, Richard L.
Published: (2013)

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
by: Momparler, Richard L, et al.
Published: (2014)

5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
by: Patra, Aditi, et al.
Published: (2011)

5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1
by: Maslov, Alexander Y., et al.
Published: (2012)

AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine
by: Tsai, Chiou-Tsun, et al.
Published: (2013)

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.
by: Richel, D. J., et al.
Published: (1991)

Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells
by: Xie, Manyun, et al.
Published: (2014)

Restoration of Epigenetically Silenced Sulfatase 1 Expression by 5-Aza-2′-Deoxycytidine Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy-Induced Apoptosis
by: Shire, Abdirashid, et al.
Published: (2015)

Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2′-deoxycytidine.
by: Almatrafi, Ahmed, et al.
Published: (2014)

Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center
by: Borgonovo, Tamara, et al.
Published: (2014)

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
by: Richel, D. J., et al.
Published: (1988)

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma
by: Geiger, Kathrin, et al.
Published: (2012)

5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma.
by: Cortvrindt, R., et al.
Published: (1987)

GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
by: Chiam, Karen, et al.
Published: (2011)

5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair
by: Orta, Manuel Luís, et al.
Published: (2013)

Effects of 5-Aza-2′-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line
by: YAN, HONGCHAO, et al.
Published: (2013)

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
by: Karahoca, Metin, et al.
Published: (2013)

5-Aza-2′-deoxycytidine Leads to Reduced Embryo Implantation and Reduced Expression of DNA Methyltransferases and Essential Endometrial Genes
by: Ding, Yu-Bin, et al.
Published: (2012)

Gene expression profiling of the synergy of 5-aza-2′-deoxycytidine and paclitaxel against renal cell carcinoma
by: Han, Tiandong, et al.
Published: (2012)

Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine in anaplastic large cell lymphoma
by: Hassler, Melanie R., et al.
Published: (2012)

Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
by: Wongtrakoongate, P, et al.
Published: (2014)

Treating Cloned Embryos, But Not Donor Cells, with 5-aza-2’-deoxycytidine Enhances the Developmental Competence of Porcine Cloned Embryos
by: HUAN, Yan Jun, et al.
Published: (2013)

Synergistic and antagonistic AML cell type-specific responses to 5-AZA-2’-Deoxycytidine and 1-H-D-Arabinofuranosylcytosine
by: Elmoneim, Abeer Abd, et al.
Published: (2014)

A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
by: Momparler, Richard L.
Published: (2012)

Delineating the effect of demethylating agent 5-aza-2′-deoxycytidine on human Caco-2 colonic carcinoma cells
by: LI, XIUMEI, et al.
Published: (2016)

DNA demethylation caused by 5-Aza-2′-deoxycytidine induces mitotic alterations and aneuploidy
by: Costa, Giuseppe, et al.
Published: (2016)

Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine
by: Vincent, Zoë L., et al.
Published: (2015)

Five-aza-2′-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells
by: Tsujioka, Takayuki, et al.
Published: (2015)

DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences
by: Ramos, María-Paz, et al.
Published: (2015)

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
by: Bouchat, Sophie, et al.
Published: (2015)

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
by: Orta, Manuel Luis, et al.
Published: (2014)

Effects of 5-aza-2′deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma
by: Zhou, X.Q., et al.
Published: (2014)

Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine
by: Ding, Xiao-Lei, et al.
Published: (2016)

5-Aza-2'-deoxycytidine acts as a modulator of chondrocyte hypertrophy and maturation in chick caudal region chondrocytes in culture
by: Haq, Samina Hyder
Published: (2016)

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
by: Sciacovelli, Marco, et al.
Published: (2016)

Low concentrations of 5-aza-2′-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression
by: Phan, Nhan Lu-Chinh, et al.
Published: (2015)

Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions
by: Yang, Xiaojing, et al.
Published: (2012)

Trichostatin A Stabilizes the Expression of Pluripotent Genes in Human Mesenchymal Stem Cells during Ex Vivo Expansion
by: Han, Bing, et al.
Published: (2013)